DSWL [DESWELL INDUSTRIES] SC 13D/A: (Original Filing)
[]
SNP [CHINA PETROLEUM & CHEMICAL] 6-K: (Original Filing)
[This Form 6-K consists of: Announcement 1 CHINA PETROLEUM & CHEMICAL CORP (a joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock Code: 0386) By Order of the Board China Petroleum & Chemical Corporation Huang Wensheng Vice President and Secretary to the Board of Directors Beijing, the PRC, 29 October 2015]
CHU [CHINA UNICOM (HONG KONG)] 6-K: (Original Filing)
[1 Announcement dated October 30, 2015 for the written approval of Major Transaction in relation to the Disposal of Telecommunications Towers and Related Assets. changes in the PRC telecommunications industry resulting from the issuance of licenses for telecommunications services by the central government of the PRC;]
MY [CHINA MING YANG WIND POWER] 6-K: (Original Filing)
[Ming Yang Announces Receipt of Preliminary Non-Binding Going Private Proposal Zhongshan, China, November 2, 2015 China Ming Yang Wind Power Group Limited (Ming Yang or the Company) (NYSE: MY), a leading wind energy solution provider in China, today announced that its Board of Directors (the Board) has received a preliminary non-binding proposal letter, dated November 2, 2015, from its] [2 CHINA MING YANG WIND POWER GROUP LIMITED Chuanwei Zhang Chairman of the Board of Directors, Chief Executive Officer 3 6-K 1 d50338d6k.htm FORM 6-K]
SNP [CHINA PETROLEUM & CHEMICAL] 6-K: (Original Filing)
[This Form 6-K consists of: (a joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock Code: 0386) CONNECTED TRANSACTION FORMATION OF JOINT VENTURE On 29 October 2015, the Company entered into the JV Agreement with SAMC in relation to the formation of the Gaoqiao Petrochemical Co. Gaoqiao Petrochemical Co. shall have a registered capital]
ZNH [CHINA SOUTHERN AIRLINES CO] 6-K: (Original Filing)
[Summary 1 1 Important Notice 1.1 1.2 All Directors attended the meeting of the Board and considered the quarterly report. 1.3 1.4 2 Major accounting data and changes of shareholders of the Company 2.1 Major accounting data Unit: Million Currency: RMB 30 September 2015 31 December 2014 Increase/ (decrease) (%) Total assets 183,862 189,697 (3.08 ) Net assets attributable to] []
SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[Sinovac Receives Clinical Trial Approval for Varicella Vaccine Candidate BEIJING, Oct. 26, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced that one of its subsidiaries, Sinovac Dalian, has received approval to begin human clinical trials on its varicella vaccine candidate. The clinical trial application for the varicella vaccine was officially accepted] []
